Results 231 to 240 of about 221,430 (290)

Combined sleep behaviors, mediating biomarkers, and incident vascular complications among individuals with type 2 diabetes: A prospective study in UK Biobank

open access: yesJournal of Diabetes Investigation, EarlyView.
Among UK Biobank participants with type 2 diabetes, combined healthy sleep behaviors were associated with lower risks of vascular complications. Lipid and inflammatory biomarkers partially mediated these associations. ABSTRACT Aims To prospectively examine how combined sleep behaviors affect vascular complications in type 2 diabetes, whether these ...
Yanqiu Zou   +18 more
wiley   +1 more source

Cumulative isotretinoin dosing, treatment response and acne relapse: A randomized controlled trial

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this randomized controlled trial, cumulative isotretinoin doses of 120 and 150 mg/kg showed similar relapse rates at 12 months. Both regimens achieved substantial and comparable reductions in inflammatory acne lesions across the face, chest and back.
Ruggero Cascio Ingurgio   +16 more
wiley   +1 more source

Risk and outcomes of adrenal crisis in primary adrenal insufficiency: Evidence from a 24‐year nationwide cohort study

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Background Adrenal crisis is a life‐threatening emergency. Despite preventive strategies, previous reports suggest increasing incidence and substantial mortality, but robust validated data are limited. Objective To assess temporal trends in adrenal crisis incidence and identify associated risk factors.
Ann‐Elin Meling Stokland   +29 more
wiley   +1 more source

Glucocorticoid-induced adrenal insufficiency: physiological dose tapering promotes recovery. [PDF]

open access: yesEndocr Connect
Mehta R   +9 more
europepmc   +1 more source

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome, affects 10%–13% of women of reproductive age and remains underdiagnosed despite its substantial health burden. The introduction of the new PMOS nomenclature in 2026 reflects a fundamental shift in understanding the condition as a lifelong endocrine ...
Maria Forslund   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy